Anxiety Disorders  >>  aticaprant (JNJ-67953964)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
aticaprant (JNJ-67953964) / J&J
NCT02218775: FASTMAS (Fast-Fail Trials in Mood and Anxiety Spectrum Disorders) Kappa Opioid Receptor Phase 1 Study

Withdrawn
1
0
US
LY2456302
Andrew Krystal, Yale University
Anxiety Disorders
04/15
04/15

Download Options